Use of darunavir/ritonavir once daily in treatment-naive pregnant woman: pharmacokinetics, compartmental exposure, efficacy and safety

AIDS. 2010 Apr 24;24(7):1083-4. doi: 10.1097/QAD.0b013e32833653b2.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • CD4 Lymphocyte Count
  • Darunavir
  • Drug Administration Schedule
  • Drug Therapy, Combination
  • Female
  • HIV Infections / drug therapy*
  • HIV Infections / immunology
  • HIV Infections / virology
  • HIV Protease Inhibitors / administration & dosage
  • HIV Protease Inhibitors / pharmacokinetics*
  • HIV-1* / drug effects
  • Humans
  • Infant, Newborn
  • Pregnancy
  • Pregnancy Complications, Infectious / drug therapy*
  • Pregnancy Complications, Infectious / metabolism
  • Pregnancy Complications, Infectious / virology
  • Ritonavir / administration & dosage
  • Ritonavir / pharmacokinetics*
  • Sulfonamides / administration & dosage
  • Sulfonamides / pharmacokinetics*
  • Treatment Outcome
  • Viral Load

Substances

  • HIV Protease Inhibitors
  • Sulfonamides
  • Ritonavir
  • Darunavir